Karyopharm Therapeutics reported $294.03M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbott ABT:US $ 74007M 1189M
Abbvie ABBV:US $ 143211M 3318M
Amgen AMGN:US $ 59196M 1969M
AstraZeneca AZN:LN 100273M 5090M
Astrazeneca AZN:US $ 100273M 5090M
Avrobio Inc AVRO:US $ 175.34M 28.49M
Biocryst Pharmaceuticals BCRX:US $ 527.72M 60.43M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Enanta Pharmaceuticals ENTA:US $ 406.82M 33.78M
Epizyme EPZM:US $ 312.19M 23.19M
GlaxoSmithKline GSK:LN 89689M 10586M
Johnson & Johnson JNJ:US $ 178355M 3663M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Macrogenics MGNX:US $ 271.44M 63.8M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Novartis NOVN:VX SF 125218M 6577M
Novartis NVS:US $ 125218M 6577M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Takeda 4502:JP Y 13178018M 479499M
Tg Therapeutics TGTX:US $ 303.03M 76.6M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Xencor XNCR:US $ 857.92M 19.71M
YTE INCY:US $ 5054.22M 120.87M